Prof. Patricia Price

University of Western Australia, Australia

Email: patricia.price@uwa.edu.au

Qualifications

1985  Ph.D., University of Western Australia, Australia

1977  M.Sc., University of Western Australia, Australia

1974  B.Sc., University of Western Australia, Australia

Publications (Selected)

1. Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL. Can We Predict Neuropathy Risk before Stavudine Prescription in a Resource-Limited Setting? AIDS Res Hum Retroviruses. 2008 24:1281-4.
2. Pemberton LA, Stone E, Price P, van Bockxmeer F, Brew BJ. The relationship between ApoE, TNFA, IL1A, IL1B and IL12B genes and HIV-1-associated dementia. HIV Med 2008 9:677-80.
3. Temple SE, Cheong KY, Price P, Waterer GW. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet. 2008 35:309-16.
4. Price P, Fernandez S, Tan DBA, James IR, Keane NM,  responsesgFrench MA. Nadir CD4 T-cell counts continue to influence interferon- in HIV patients who began antiretroviral treatment with advanced immunodeficiency. J Acquir Immune Defic Syndr. 2008;49:462-464.
5. Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation. 2008 5:36.
6. Price P, Lim A, French M. Immune reconstitution syndrome is not a single entity. AIDS. 2008; 22:911 (letter).
7. Crane M, Oliver B, Matthews G, Avihingsanon A, Ubolyam S, Markovska V, Chang JJ, Dore GJ, Price P, Visvanathan K, French M, Ruxrungtham K, Lewin SR. Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy. J Infect Dis. 2009;199:974-81.
8. Temple S, Cheong K, Waterer G, Price P. Pathogenic bacteria and TNF do not induce production of macrophage migration inhibitory factor (MIF) by human monocytes. Cytokine 2009 46:316-8.
9. Price P, James I. IL1A alleles associate with a virological response to ART in HIV patients beginning therapy with advanced disease. AIDS 2009 23:1173-6.
10. Valente FP, Tan CRT, Phipps M, Witt CS, Kaur G, Gut I, Allcock R, Price P TNF Block haplotypes associated with conserved MHC haplotypes in European, Asian and Australian Aboriginal donors. Tissue Antigens. 2009 74:57-61.
11. Lim AFY, French MA, Price P. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and ART. JAIDS 2009 51:248-57
12. Tan DBA, Fernandez S, French M, Price P. Production of interferon-gamma by circulating Natural Killer cells is impaired in HIV patients responding to long-term antiretroviral therapy. Clin Immunol. 2009 132:63-70.
13. Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S, Kamarulzaman A, Price P. Age and height predict neuropathy risk in HIV patients prescribed stavudine. Neurol2009 73:315-20.
14. Valente FP, Tan CRT, Temple SE, Phipps M, Witt CS, Kaur G, Gut I, McGinn S, Allcock RN, Chew C Price P. The evolution and diversity TNF Block Haplotypes in European, Asian and Australian Aboriginal Populations. Genes & Immunity. 2009  10:607-15
15. Price P Agarawal U, Murdoch D, Elliot J, Lewin S, French M. 2009. Immune restoration diseases reflect diverse immunopathological mechanisms. Clin Microbiol Rev, 22:651-63  (IF = 16.4)
16. Tanaskovic S, Fernandez S, Price P, French MA. CD31 marks recent thymic emigrants amongst CD4+ but not CD8+ T-cells, in HIV patients on ART. Immunol Cell Biol, 2010 88:321-7
17. Lim A, Allison C, Tan DB, Oliver B, Price P, Waterer G. Immunological markers  of lung disease due to non-tuberculous mycobacteria. Dis Markers. 2010;29:103-9.
18. Lim A, Allison C, Price P, Waterer G. Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency. Clin Immunol. 2010;137:296-302.
19. Oliver BG, Elliott JH, Price P, Phillips M, Saphonn V, Vun MC, Kaldor JM, Cooper DA, French MA. Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis. 2010;202:1728-37.
20. Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S, Ismail R, Phipps M, Aghafar Z, Gut I, Price P. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue Antigens. 2010 Sep 30.
21. Oliver BG, Elliott JH, Saphonn V, Vun MC, French MA, Price P. Interferon-γ and IL-5 Production Correlate Directly in HIV Patients Co-Infected with Mycobacterium tuberculosis with or without Immune Restoration Disease. AIDS Res Hum Retroviruses. 2010 Dec;26(12):1287-9
22. Tan JH, Price P, Gut I, Stacey MC, Warrington NM, Wallace HJ. Characterization of tumor necrosis factor-α block haplotypes associated with susceptibility to chronic venous leg ulcers in Caucasian patients. Hum Immunol. 2010;71(12):1214-9.
23. Affandi JS, Price P, Waterer G. Can immunogenetics illuminate the diverse manifestations of respiratory infections? Ther Adv Respir Dis. 2010;4:161-76. Review.
24. Lee S, Varano J, Flexman JP, Cheng W, Watson MW, Rossi E, Adams LA, Bulsara M, Price P. Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus. Dis Markers. 2010;28:273-80.
25. Hammond T, Lee S, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P. Toll-like receptor (TLR) expression on CD4+ and CD8+ T-cells in patients chronically infected with hepatitis C virus. Cell Immunol. 2010;264:150-5.
26. Hammond T, Lee S, Watson MW, Flexman JP, Cheng W, Price P. Decreased IFNγ production correlates with diminished production of cytokines by dendritic cells in patients infected with hepatitis C virus and receiving therapy. J Viral Hepat. 2010 Jun 7.
27. Cherry CL, Affandi JS, Brew BJ, Creighton J, Djauzi S, Hooker DJ, Imran D, Kamarulzaman A, Kamerman P, McArthur JC, Moore RD, Price P, Smyth K, Tan IL, Vanar S, Wadley A, Wesselingh SL, Yunihastuti E. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV. Neurology. 2010;74:1538-42.
28. Lee S, Hammond T, Watson MW, Flexman JP, Cheng W, Fernandez S, Price P. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy? Clin Exp Immun. 2010;161:118-26.
29. Lee S, Watson MW, Flexman JP, Cheng W, Hammond T, Price P. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. J Med Virol. 2010;82:568-74.